The hottest new anti-aging treatment? Cadaver skin

Key Points:

• South Korea has developed an anti-aging injectable treatment called Elravie Re2O, made from human skin extracellular matrix (ECM) derived from deceased donors, designed to regenerate and strengthen skin by providing a natural scaffold for cell growth.
• The treatment is distinct from other skin boosters as it rebuilds the skin's underlying structure rather than just stimulating collagen production, with patients reporting improvements in skin texture, pore size, and overall resilience.
• While some users praise the noticeable results and minimal pain, others report significant discomfort during the procedure, and ethical concerns have been raised about using human tissue for cosmetic purposes instead of essential reconstructive needs.
• Although Re2O is not yet FDA-approved in the US, some clinics are already offering it, and the manufacturer, L&C Bio Co., plans to seek official approval and launch the treatment in the US market by 2027.
• Experts advise caution, emphasizing the need for consultation with qualified medical professionals due to unresolved questions about the treatment's long-term safety and effectiveness.